catechin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levites, Y; Mandel, S; Maor, G; Weinreb, O; Youdim, MB | 1 |
| Cho, MH; Choi, JY; Chung, WG; Jin, BK; Kim, DJ; Park, CS; Pie, JE | 1 |
| Mandel, S; Maor, G; Youdim, MB | 1 |
| Anandhan, A; Essa, MM; Manivasagam, T; Radhiga, T; Rao, S; Tamilselvam, K | 1 |
| Anandhan, A; Essa, MM; Manivasagam, T | 1 |
| Liang, Z; Zhou, T; Zhu, M | 1 |
6 other study(ies) available for catechin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catalase; Catechin; Dopamine; Dopamine Agents; Flavonoids; Free Radical Scavengers; Immunohistochemistry; Mice; Mice, Inbred C57BL; Monoamine Oxidase; MPTP Poisoning; Nerve Degeneration; Neurons; Oxidative Stress; Phenols; Polymers; Rats; Superoxide Dismutase; Tea; Tyrosine 3-Monooxygenase | 2001 |
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Catechin; Dopamine Agents; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Parkinson Disease, Secondary; RNA, Messenger; Substantia Nigra; Tea; Tyrosine 3-Monooxygenase | 2002 |
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Apomorphine; Catechin; Disease Models, Animal; Free Radicals; Iron; Iron Chelating Agents; Lewy Bodies; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Substantia Nigra; Synucleins; Ubiquitin | 2004 |
Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biflavonoids; Catechin; Dopaminergic Neurons; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Pilot Projects; Polyphenols; Probenecid; Random Allocation; Substantia Nigra; Tea | 2012 |
Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Biflavonoids; Catechin; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dyskinesias; Encephalitis; Glial Fibrillary Acidic Protein; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Probenecid; Proto-Oncogene Proteins c-bcl-2; Reaction Time | 2013 |
(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catechin; Disease Models, Animal; Dopaminergic Neurons; Immunomodulation; Male; Mice; Neuroprotective Agents; Parkinson Disease; T-Lymphocyte Subsets; Tyrosine 3-Monooxygenase | 2018 |